Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2022.822949
Abstract: The therapy of neurodegenerative diseases such as Parkinson’s disease (PD) is still limited to the treatment of symptoms and primarily aimed at compensating for dopaminergic hypofunction. Numerous disease-modifying therapies currently in the pipeline attempt to… read more here.
Keywords: genetics biomarkers; disease; parkinson disease; monogenetic forms ... See more keywords